600521 华海药业
已收盘 10-16 15:00:00
资讯
新帖
简况
股市必读：华海药业新发布《浙江华海药业股份有限公司第九届董事会第十七次临时会议决议公告》
证券之星 · 10-16 01:47
股市必读：华海药业新发布《浙江华海药业股份有限公司第九届董事会第十七次临时会议决议公告》
华海药业最新公告：控股子公司华奥泰拟增资扩股引入不超3.5亿元外部投资人
证券之星 · 10-15 20:19
华海药业最新公告：控股子公司华奥泰拟增资扩股引入不超3.5亿元外部投资人
华海药业：华奥泰拟增资不超过3.5亿元
格隆汇 · 10-15 20:17
华海药业：华奥泰拟增资不超过3.5亿元
华海药业最新公告：拟向参股公司华海天衡增资约1.97亿元
证券之星 · 10-12
华海药业最新公告：拟向参股公司华海天衡增资约1.97亿元
华海药业：拟1.97亿元同比例增资参股公司华海天衡
格隆汇 · 10-12
华海药业：拟1.97亿元同比例增资参股公司华海天衡
股市必读：华海药业新发布《浙江华海药业股份有限公司可转换公司债券转股结果暨股份变动公告》
证券之星 · 10-12
股市必读：华海药业新发布《浙江华海药业股份有限公司可转换公司债券转股结果暨股份变动公告》
华海药业前三季度归母净利润预增超170%
经济参考网 · 10-09
华海药业前三季度归母净利润预增超170%
逆转！药ETF华宝、医疗ETF华宝携手翻红！美年健康领涨超6%，华海药业五连涨，前三季净利预增逾170%
新浪基金 · 10-09
逆转！药ETF华宝、医疗ETF华宝携手翻红！美年健康领涨超6%，华海药业五连涨，前三季净利预增逾170%
华海药业（600521）10月8日主力资金净买入4041.35万元
证券之星 · 10-09
华海药业（600521）10月8日主力资金净买入4041.35万元
股市必读：华海药业（600521）预计2026年1-9月扣非后净利润盈利6.62亿元至7.43亿元
证券之星 · 10-08
股市必读：华海药业（600521）预计2026年1-9月扣非后净利润盈利6.62亿元至7.43亿元
华海药业：预计2026年前三季度净利10.28亿元-11.03亿元，同比增170%-190%
格隆汇 · 10-07
华海药业：预计2026年前三季度净利10.28亿元-11.03亿元，同比增170%-190%
华海药业（600521）披露“华海转债”到期兑付暨摘牌第二次提示公告，9月24日股价下跌3.23%
证券之星 · 09-24
华海药业（600521）披露“华海转债”到期兑付暨摘牌第二次提示公告，9月24日股价下跌3.23%
华海药业（600521）披露“华海转债”到期兑付暨摘牌提示公告，9月23日股价下跌0.97%
证券之星 · 09-23
华海药业（600521）披露“华海转债”到期兑付暨摘牌提示公告，9月23日股价下跌0.97%
华海药业最新公告：阿哌沙班片获德国上市许可
证券之星 · 09-14
华海药业最新公告：阿哌沙班片获德国上市许可
股市必读：华海药业新发布《浙江华海药业股份有限公司关于股东部分股份质押的公告》
证券之星 · 09-14
股市必读：华海药业新发布《浙江华海药业股份有限公司关于股东部分股份质押的公告》
每周股票复盘：华海药业（600521）周明华质押1300万股为上海国际医学中心融资担保
证券之星 · 09-13
每周股票复盘：华海药业（600521）周明华质押1300万股为上海国际医学中心融资担保
华海药业（600521）披露股东部分股份质押公告，9月10日股价下跌2.14%
证券之星 · 09-10
华海药业（600521）披露股东部分股份质押公告，9月10日股价下跌2.14%
股市必读：华海药业新发布《浙江华海药业股份有限公司关于获得药品注册证书的公告》
证券之星 · 08-31
股市必读：华海药业新发布《浙江华海药业股份有限公司关于获得药品注册证书的公告》
每周股票复盘：华海药业（600521）Q2净利增227.2%
证券之星 · 08-30
每周股票复盘：华海药业（600521）Q2净利增227.2%
华海药业（600521）披露2026年半年度募集资金存放、管理与实际使用情况的专项报告，8月27日股价上涨1.46%
证券之星 · 08-27
华海药业（600521）披露2026年半年度募集资金存放、管理与实际使用情况的专项报告，8月27日股价上涨1.46%
加载更多
公司概况
公司名称：
浙江华海药业股份有限公司
所属行业：
医药制造业
上市日期：
2003-03-04
主营业务：
浙江华海药业股份有限公司的主营业务是多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品是心血管类原料药、精神障碍类原料药、神经系统类原料药、抗感染类原料药、消化类治疗药、呼吸类治疗药、抗肿瘤类治疗药、内分泌类治疗药。
发行价格：
15.55
{"stockData":{"symbol":"600521","market":"SH","secType":"STK","nameCN":"华海药业","latestPrice":16.51,"timestamp":1792134000000,"preClose":16.49,"halted":0,"volume":40090352,"delay":0,"changeRate":0.0012,"floatShares":1497000000,"shares":1497000000,"eps":0.4194,"marketStatus":"已收盘","change":0.02,"latestTime":"10-16 15:00:00","open":16.67,"high":17.19,"low":16.34,"amount":674000000,"amplitude":0.0515,"askPrice":16.51,"askSize":11,"bidPrice":16.5,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.4194,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792373400000},"marketStatusCode":5,"adr":0,"adjPreClose":16.49,"symbolType":"stock","openAndCloseTimeList":[[1792114200000,1792121400000],[1792126800000,1792134000000]],"highLimit":18.14,"lowLimit":14.84,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1497253704,"isCdr":false,"pbRate":2.59,"roa":"--","peRate":39.365761,"roe":"7.92%","epsLYR":0.18,"committee":-0.256614,"marketValue":24720000000,"turnoverRate":0.0268,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-20。","floatMarketCap":24720000000},"requestUrl":"/m/hq/s/600521","defaultTab":"news","newsList":[{"id":"2675534354","title":"股市必读：华海药业新发布《浙江华海药业股份有限公司第九届董事会第十七次临时会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675534354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675534354?lang=zh_cn&edition=full","pubTime":"2026-10-16 01:47","pubTimestamp":1792086429,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江华海药业股份有限公司第九届董事会第十七次临时会议决议公告浙江华海药业股份有限公司第九届董事会第十七次临时会议审议通过《关于控股子公司增资扩股并引入投资人的议案》。本次交易完成后，华海药业持有华奥泰股权比例不低于81.8643%，华奥泰仍纳入公司合并报表范围。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600002186.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0185","600521","BK0028","BK0070","BK0201","BK0012","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675582831","title":"华海药业最新公告：控股子公司华奥泰拟增资扩股引入不超3.5亿元外部投资人","url":"https://stock-news.laohu8.com/highlight/detail?id=2675582831","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675582831?lang=zh_cn&edition=full","pubTime":"2026-10-15 20:19","pubTimestamp":1792066759,"startTime":"0","endTime":"0","summary":"华海药业(600521.SH)公告称，公司控股子公司上海华奥泰生物药业股份有限公司拟实施增资扩股并引入长三角基金等外部投资人，合计投资不超过3.5亿元，预计取得增资后股权比例不超过5.9829%。本次增资完成后，公司持有华奥泰股份比例不低于81.8643%，华奥泰仍为公司合并报表范围内子公司。本次交易定价以华奥泰投前估值55亿元为基础，每1元注册资本增资价格约10.9375元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500036626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","600521","BK0188","BK0070","BK0185","BK0201","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675294584","title":"华海药业：华奥泰拟增资不超过3.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675294584","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675294584?lang=zh_cn&edition=full","pubTime":"2026-10-15 20:17","pubTimestamp":1792066632,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["600521","BK0028","BK0012","BK0185","BK0070","BK0188","BK0239","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674087488","title":"华海药业最新公告：拟向参股公司华海天衡增资约1.97亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674087488","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674087488?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:30","pubTimestamp":1791811800,"startTime":"0","endTime":"0","summary":"华海药业(600521.SH)公告称，公司拟与王晶翼、云枢天衡共同向参股公司华海天衡增资合计5.97亿元，其中公司增资约1.97亿元。增资完成后，公司持有华海天衡的股份比例不变。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200034098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0188","BK0070","BK0239","BK0185","600521","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674082388","title":"华海药业：拟1.97亿元同比例增资参股公司华海天衡","url":"https://stock-news.laohu8.com/highlight/detail?id=2674082388","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674082388?lang=zh_cn&edition=full","pubTime":"2026-10-12 21:28","pubTimestamp":1791811724,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0201","BK0012","BK0028","BK0188","BK0070","BK0239","600521","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674884343","title":"股市必读：华海药业新发布《浙江华海药业股份有限公司可转换公司债券转股结果暨股份变动公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674884343","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674884343?lang=zh_cn&edition=full","pubTime":"2026-10-12 01:00","pubTimestamp":1791738042,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，华海药业报收于17.45元，上涨4.8%，换手率4.82%，成交量72.2万手，成交额12.38亿元。公司公告汇总：截至2026年9月30日，“华海转债”累计转股7,927股，占转股前总股本的0.000545%，未转股余额为1,842,356,000元，占发行总额的99.9868%。公司公告汇总浙江华海药业股份有限公司可转换公司债券转股结果暨股份变动公告“华海转债”自2021年5月6日起进入转股期。转股价格由初始34.66元/股调整至16.50元/股，系因利润分配及转股价格下修所致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200000322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0070","BK0012","600521","BK0239","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674605856","title":"华海药业前三季度归母净利润预增超170%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674605856","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674605856?lang=zh_cn&edition=full","pubTime":"2026-10-09 18:11","pubTimestamp":1791540660,"startTime":"0","endTime":"0","summary":"日前，浙江华海药业股份有限公司发布2026年前三季度业绩预增公告。数据显示，2026年前三季度，公司预计实现归母净利润10.28亿元至11.03亿元，同比增长约170%到190%；预计实现扣非净利润6.62亿元至7.43亿元，同比增长约145%到175%。华海药业同时表示，报告期内，公司归母净利润较去年同期增长约170%到190%，除上述因素影响外，本期处置子公司华海天衡(上海)药物研究股份有限公司67%股权产生的收益等亦影响利润增加。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-09/doc-iniurruh1017141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674761835","title":"逆转！药ETF华宝、医疗ETF华宝携手翻红！美年健康领涨超6%，华海药业五连涨，前三季净利预增逾170%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674761835","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674761835?lang=zh_cn&edition=full","pubTime":"2026-10-09 14:23","pubTimestamp":1791526980,"startTime":"0","endTime":"0","summary":"10月9日午后，A股奋力拉升，医药行情随市逆转，药ETF华宝、医疗ETF华宝双双翻红！个股大面积翻红，美年健康涨超6%领涨医疗板块，英科医疗、卫宁健康等多股涨超4%。制药板块反弹力度更强，逾40股飘红，神州细胞涨超5%，华海药业涨逾4%，至此斩获5连涨。10月7日晚，华海药业发布A股首份药企三季报预告：前三季度，公司归母净利润预计在10.28亿元到11.03亿元之间，同比增长约170%到190%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2026-10-09/doc-iniurfei6901640.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0070","BK0012","562050","BK0185","BK0201","LU2097828557.USD","BK0188","BK0239","BK0114","LU2097828631.EUR","512170","BK0077","002044","600521","BK0146","LU2097828714.EUR","BK0196","BK0236","LU2097828805.USD","LU2097828474.EUR","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674889302","title":"华海药业（600521）10月8日主力资金净买入4041.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674889302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674889302?lang=zh_cn&edition=full","pubTime":"2026-10-09 08:24","pubTimestamp":1791505488,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，华海药业报收于16.65元，上涨1.9%，换手率4.09%，成交量61.24万手，成交额10.28亿元。近5日资金流向一览见下表：华海药业融资融券信息显示，融资方面，当日融资买入1.21亿元，融资偿还6201.8万元，融资净买入5913.14万元。华海药业主营业务：多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900006055.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0028","BK0239","BK0185","BK0012","600521","BK0188","BK0201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673901447","title":"股市必读：华海药业（600521）预计2026年1-9月扣非后净利润盈利6.62亿元至7.43亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673901447","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673901447?lang=zh_cn&edition=full","pubTime":"2026-10-08 01:24","pubTimestamp":1791393854,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，华海药业报收于16.34元，上涨2.19%，换手率1.42%，成交量21.24万手，成交额3.46亿元。公司公告汇总：为全资子公司提供合计不超过28亿元贷款的连带责任保证，担保总额占净资产67.03%。业绩披露要点业绩预告预计2026年1-9月扣非后净利润盈利6.62亿元至7.43亿元；归属净利润盈利10.28亿元至11.03亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673095428","title":"华海药业：预计2026年前三季度净利10.28亿元-11.03亿元，同比增170%-190%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673095428","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673095428?lang=zh_cn&edition=full","pubTime":"2026-10-07 15:33","pubTimestamp":1791358426,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0201","BK0239","BK0012","BK0188","BK0028","600521","BK0070","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669466722","title":"华海药业（600521）披露“华海转债”到期兑付暨摘牌第二次提示公告，9月24日股价下跌3.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669466722","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669466722?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:36","pubTimestamp":1790242618,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，华海药业报收于15.88元，较前一交易日下跌3.23%，最新总市值为237.76亿元。该股当日开盘16.22元，最高16.43元，最低15.75元，成交额达4.37亿元，换手率为1.83%。公司于近日发布《关于“华海转债”到期兑付暨摘牌的第二次提示公告》。公告显示，“华海转债”将于2026年11月1日到期，兑付登记日为2026年10月30日，兑付本息金额为110元/张（含税），兑付资金发放日为2026年11月2日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400030454.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0070","BK0188","BK0201","600521","BK0012","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669104584","title":"华海药业（600521）披露“华海转债”到期兑付暨摘牌提示公告，9月23日股价下跌0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669104584","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669104584?lang=zh_cn&edition=full","pubTime":"2026-09-23 17:29","pubTimestamp":1790155766,"startTime":"0","endTime":"0","summary":"截至2026年9月23日收盘，华海药业报收于16.41元，较前一交易日下跌0.97%，最新总市值为245.7亿元。浙江华海药业股份有限公司于近日发布《关于“华海转债”到期兑付暨摘牌的第一次提示公告》。公告显示，华海转债将于2026年11月1日到期，兑付登记日为2026年10月30日，兑付本息金额为110元人民币/张（含税），兑付资金发放日为2026年11月2日。可转债最后交易日为2026年10月27日，自2026年10月28日起停止交易，可转债摘牌日为2026年11月2日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300029900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","600521","BK0201","BK0185","BK0028","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667652561","title":"华海药业最新公告：阿哌沙班片获德国上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2667652561","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667652561?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:39","pubTimestamp":1789378787,"startTime":"0","endTime":"0","summary":"华海药业(600521.SH)公告称，公司子公司华海欧洲公司近日收到德国联邦药品和医疗器械管理局核准签发的阿哌沙班片上市许可。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400023698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0012","BK0028","BK0188","FDAXmain","BK0070","FDXSmain","BK0239","FDXMmain","600521","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667687082","title":"股市必读：华海药业新发布《浙江华海药业股份有限公司关于股东部分股份质押的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667687082","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667687082?lang=zh_cn&edition=full","pubTime":"2026-09-14 01:12","pubTimestamp":1789319529,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江华海药业股份有限公司关于股东部分股份质押的公告浙江华海药业股份有限公司5%以上股东周明华先生持有公司股份224,418,890股，占公司总股本的14.99%。本次质押后，周明华累计质押股份为58,000,000股，占其所持股份的25.84%，占公司总股本的3.87%。已质押股份无限售或冻结情形，未质押股份亦无冻结或限售情况。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400000497.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0012","BK0185","BK0028","BK0070","600521","BK0201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667507588","title":"每周股票复盘：华海药业（600521）周明华质押1300万股为上海国际医学中心融资担保","url":"https://stock-news.laohu8.com/highlight/detail?id=2667507588","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667507588?lang=zh_cn&edition=full","pubTime":"2026-09-13 01:50","pubTimestamp":1789235423,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，华海药业报收于15.37元，较上周的15.99元下跌3.88%。本周关注点公司公告汇总：周明华质押1300万股，占其所持股份5.79%，用于上海国际医学中心有限公司融资担保。本次质押13,000,000股，占其所持股份的5.79%，占公司总股本的0.87%，质押起始日为2026年9月9日，质权人为平安银行股份有限公司上海分行，质押用途为上海国际医学中心有限公司的融资提供质押担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0012","BK0070","BK0028","BK0185","BK0042","BK0114","BK0239","BK0146","BK0077","BK0201","000516","BK0046","BK0181","BK0188","600521","BK0236"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666591894","title":"华海药业（600521）披露股东部分股份质押公告，9月10日股价下跌2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666591894","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666591894?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:08","pubTimestamp":1789049305,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，华海药业报收于15.54元，较前一交易日下跌2.14%，最新总市值为232.67亿元。该股当日开盘15.78元，最高15.87元，最低15.45元，成交额达2.79亿元，换手率为1.2%。公告显示，公司5%以上股东周明华先生持有公司股份224,418,890股，占公司总股本的14.99%。本次质押后，周明华累计质押股份为58,000,000股，占其所持股份的25.84%，占公司总股本的3.87%。已质押股份无限售或冻结情形，未质押股份亦无冻结或限售情况。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000041877.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","BK0012","BK0188","BK0028","600521","BK0070","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663198042","title":"股市必读：华海药业新发布《浙江华海药业股份有限公司关于获得药品注册证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663198042","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663198042?lang=zh_cn&edition=full","pubTime":"2026-08-31 02:14","pubTimestamp":1788113651,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，华海药业报收于16.46元，下跌1.08%，换手率1.46%，成交量21.9万手，成交额3.6亿元。公司公告汇总浙江华海药业股份有限公司关于获得药品注册证书的公告浙江华海药业股份有限公司下属全资子公司浙江华海制药科技有限公司近日收到国家药品监督管理局核准签发的利奥西呱片《药品注册证书》，规格为0.5mg、1mg、2.5mg，注册分类为化学药品4类，审批结论为符合药品注册要求，批准注册。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100000740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0185","BK0188","BK0012","600521","BK0201","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010615","title":"每周股票复盘：华海药业（600521）Q2净利增227.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010615","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010615?lang=zh_cn&edition=full","pubTime":"2026-08-30 02:25","pubTimestamp":1788027910,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，华海药业报收于16.46元，较上周的16.62元下跌0.96%。本周，华海药业8月27日盘中最高价报16.88元。华海药业当前最新总市值246.45亿元，在化学制药板块市值排名16/149，在两市A股市值排名807/5211。第二季度单季主营收入25.77亿元，同比上升20.0%；单季度归母净利润3.67亿元，同比上升227.2%；单季度扣非净利润2.9亿元，同比上升267.94%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600521","BK0188","BK0201","BK0239","BK0070","BK0012","BK0185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662011587","title":"华海药业（600521）披露2026年半年度募集资金存放、管理与实际使用情况的专项报告，8月27日股价上涨1.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662011587","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662011587?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:22","pubTimestamp":1787829738,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，华海药业报收于16.64元，较前一交易日上涨1.46%，最新总市值为249.14亿元。公司于近日披露《浙江华海药业股份有限公司关于2026年半年度募集资金存放、管理与实际使用情况的专项报告》。公告显示，2020年可转债募集资金已全部使用完毕，相关账户已注销。向特定对象发行股票的募集资金净额58,231.94万元，截至2026年6月30日余额为17,344.05万元。闲置募集资金用于现金管理及暂时补充流动资金均按规定执行，无违规情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0201","BK0070","BK0012","600521","BK0239","BK0028","BK0185"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792190872841,"stockEarnings":[{"period":"1week","weight":-0.0539},{"period":"1month","weight":0.0185},{"period":"3month","weight":0.0223},{"period":"6month","weight":-0.0151},{"period":"1year","weight":-0.1637},{"period":"ytd","weight":-0.0203}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0451},{"period":"3month","weight":-0.0127},{"period":"6month","weight":-0.0827},{"period":"1year","weight":-0.0511},{"period":"ytd","weight":-0.0636}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江华海药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"83272人(较上一季度减少6.79%)","perCapita":"17980股","listingDate":"2003-03-04","address":"浙江省台州市临海市汛桥镇汛大路88号","registeredCapital":"149725万元","survey":" 浙江华海药业股份有限公司的主营业务是多剂型的仿制药、生物药、创新药及特色原料药的研发、生产和销售。公司的主要产品是心血管类原料药、精神障碍类原料药、神经系统类原料药、抗感染类原料药、消化类治疗药、呼吸类治疗药、抗肿瘤类治疗药、内分泌类治疗药。","listedPrice":15.55},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华海药业,600521,华海药业股票,华海药业股票老虎,华海药业股票老虎国际,华海药业行情,华海药业股票行情,华海药业股价,华海药业股市,华海药业股票价格,华海药业股票交易,华海药业股票购买,华海药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华海药业(600521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华海药业(600521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}